Care Anywhere with Community Paramedics Program to Reduce Hospitalization

Overview

About this study

The purpose of this study is to evaluate the effectiveness of the Care Anywhere with Community Paramedics (CACP) program in reducing hospitalizations among patients being cared for in the emergency department or hospital.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Aim 1:

  • Clinicians (physicians, Nurse Practitioners, Physician Assistants), nurses, community paramedics, administrators, care coordinators, and other stakeholders likely to be engaged in the CACP program.

Inclusion Criteria - Aim 2:

  • Adults (age ≥ 18 years) who are:
    • Currently admitted to the ED, hospital; or are
    • In a pre-hospital setting but being considered for referral to the ED or hospital at Mayo Clinic Rochester, MN and Barron, WI but do not require hospital-level monitoring or care other than services that could be delivered by CPs in the ambulatory setting if such services were available to them.
  • Eligible participants have to reside within an approximately 40-mile radius of Rochester, MN or within the service radius of Barron, WI. 
  • Participants who require assistance with activities of daily living, or who are at increased risk for falls, need to have a caregiver available at home. For the purposes of the trial, “residence” and “home” refer to the place where the participant will be physically located after clinic, ED, or hospital discharge, and can include a hotel or another housing arrangement (i.e., not only their permanent residence).

Inclusion Criteria - Aim 3:

  • All community paramedics (up to 18), clinicians who referred participants enrolled in the CACP intervention arm (up to 100), administrators involved with the CACP program (up to 30), and Mayo Clinic Ambulance leaders (up to 20) will be surveyed. 
  • All community paramedics (up to 18), purposive sample of participants enrolled in the CACP intervention arm (up to 35), and a purposive sample of clinicians, administrators, administrators, and Ambulance leaders (up to 35) will be interviewed.
  • Patient participants will be purposively sampled to ensure diversity of geography, age, sex, race and ethnicity, and clinical diagnosis for CACP program referral. Clinician and administrator participants will be purposively sampled to ensure representation of different ED and hospital service lines and frequency of referrals to the CACP program.

Exclusion Criteria - Aim 1:​​

  •  
  • ​​​No exclusion criteria.

Exclusion Criteria - Aim 2:​​

  • Referring clinician believes the patient requires referral to the ED (for patients in the pre-hospital setting) or hospital admission (for patients in the ED or hospital)
  • Not meeting criteria outlined in the Community Paramedic Referral Guide
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
  • Clinical, behavioral, or cognitive instability, determined by the referring clinician or the CACP service
  • Living conditions unsafe for CPs to enter (e.g., patient refuses to secure weapons or animals prior to CP’s arrival)
  • Enrolled in the trial during an earlier hospitalization or ED visit.

Exclusion Criteria - Aim 3:​​

  • There will be no exclusion criteria for Aim 3 clinicians or other clinical or administrative stakeholders.
  • Patient participants will be excluded if they:
    • Have a communication barrier due to medical illness or cognitive impairment; or
    • Are seriously ill or hospitalized at the time of interview recruitment.

Eligibility last updated 3/16/22. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Grace Lin, M.D., M.B.A.

Closed for enrollment

Contact information:

Rozalina McCoy M.D., M.S.

(507) 538-7955

McCoy.Rozalina@mayo.edu

Eau Claire, Wis.

Mayo Clinic principal investigator

Robert Peterson, M.D.

Closed for enrollment

Contact information:

Wendy Sundt CCRP

(507) 255-1857

Sundt.Wendy@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20523720

Mayo Clinic Footer